Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma.

Karabajakian, Andy; Garrivier, Thibaut; Crozes, Carole; Gadot, Nicolas; Blay, Jean-Yves; Bérard, Frédéric; Céruse, Philippe; Zrounba, Philippe; Saintigny, Pierre; Mastier, Charles; Fayette, Jérôme.

Affiliation

Karabajakian A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Garrivier T; Department of Radiology, Centre Léon Bérard, Lyon, France.
Crozes C; Department of Pathology, Centre Léon Bérard, Lyon, France.
Gadot N; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Bérard F; Department of Allergology and Clinical Immunology, CHU Lyon-Sud, Pierre-Bénite, France.
Céruse P; Department of Head and Neck Surgery, Hôpital Universitaire de la Croix-Rousse, Lyon, France.
Zrounba P; Department of Head and Neck Surgery, Centre Léon Bérard, Lyon, France.
Saintigny P; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
Mastier C; Department of Radiology, Centre Léon Bérard, Lyon, France.
Fayette J; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.

Oncotarget ; 13: 1305, 2022 Dec 06.

Article in En | MEDLINE | ID: mdl-36473141

Full text: 1 Database: MEDLINE Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Language: En Year: 2022 Type: Article